SCHEMBL20766199

SCHEMBL20766199

CNS(=O)(=O)c1ccc(NC2CCCCC2)c(C(=O)OC)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 1/20 0.76
NPC1 O15118 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
CHEK1 O14757 1/20 0.43
NTRK1 P04629 1/20 0.43
MET P08581 1/20 0.43
PIM1 P11309 1/20 0.43
LTK P29376 1/20 0.43
GRK5 P34947 1/20 0.43
MAP2K2 P36507 1/20 0.43
CDK8 P49336 1/20 0.43
NEK2 P51955 1/20 0.43
LIMK1 P53667 1/20 0.43
TYRO3 Q06418 1/20 0.43
MAP4K2 Q12851 1/20 0.43
DYRK1A Q13627 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767111 0.84 YAP1 (0.58) YAP1L3MBTL1LMNAKMT2AMEN1
SCHEMBL30409578 0.84 YAP1 (0.58) YAP1L3MBTL1LMNAKMT2AMEN1
SCHEMBL20767156 0.82 YAP1 (0.53) YAP1NPC1L3MBTL1LMNAKMT2A
SCHEMBL22635665 0.81 YAP1 (0.54) YAP1NPC1LMNAKMT2AMEN1
SCHEMBL20779593 0.81 YAP1 (0.54) YAP1NPC1LMNAKMT2AMEN1
SCHEMBL20779761 0.80 YAP1 (0.50) YAP1NPC1LMNAKMT2AMEN1
SCHEMBL20766235 0.79 POLB (0.51) YAP1LMNAKMT2AMEN1GPR55
SCHEMBL22646186 0.79 YAP1 (0.52) YAP1NPC1LMNAKMT2AMEN1
SCHEMBL20779790 0.79 YAP1 (0.52) YAP1NPC1LMNAKMT2AMEN1
SCHEMBL2830062 0.79 YAP1 (0.48) YAP1NPC1L3MBTL1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111542315-B Benzosulfonyl compounds 维瓦斯治疗公司 2023-05-12 CN disclosed
EP-3691623-B1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS INC (US) 2022-10-05 EP disclosed
US-11192865-B2 Benzosulfonyl compounds VIVACE THERAPEUTICS, INC. (US) 2021-12-07 US disclosed
US-11192865-B2 Benzosulfonyl compounds VIVACE THERAPEUTICS, INC. (US) 2021-12-07 US disclosed
US-20200354325-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. 2020-11-12 US disclosed
US-20200354325-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. 2020-11-12 US disclosed
CN-111542315-A Benzosulfonyl compounds 维瓦斯治疗公司 2020-08-14 CN disclosed
EP-3691623-A1 BENZOSULFONYL COMPOUNDS Vivace Therapeutics, Inc. (US) 2020-08-12 EP disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 WO disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192865-B2 Benzosulfonyl compounds YAP1, TEAD2, TEAD1 YAP1 1/4885NPC1 2814/4885L3MBTL1 1250/4885
US-20200354325-A1 BENZOSULFONYL COMPOUNDS YAP1, TEAD2, TEAD1 YAP1 1/4885NPC1 2814/4885L3MBTL1 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.